Samyang Holdings Corp

Based in Seoul, South Korea, Samyang Holdings Corporation, founded in 1924, operates across a diverse portfolio of sectors, encompassing chemicals, food, packaging, pharmaceuticals, and information technology. Within its chemical and materials segment, the company manufactures a variety of high-value products, such as terephthalic acid, polycarbonate (PC) resins, bisphenol-A, engineering plastics, PC and polybutylene terephthalate compounds, PET bottles, and long fiber reinforced thermoplastics. Its food division supplies health and wellness products alongside starch sugar, and manages a chain of Seven Springs salad and brunch restaurants, complementing them with Café Seven Springs bakeries. In the pharmaceutical realm, Samyang is responsible for developing anti-cancer medications like Genexol and Nanoxel PM, the NicoStop smoking cessation patch, and biodegradable sutures including Trisorb and Monosorb, with these products distributed to 80 countries globally. Additionally, the corporation extends its expertise to IT services, offering consulting for system management and integration, e-business solutions, and enterprise software such as ERP, e-HR, MES, and mobile services to clients in the public, financial, and manufacturing industries.